Navigation Links
Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis

EVRY, France, April 04, 2007 /PRNewswire/ -- Novagali Pharma, an emerging ophthalmic pharmaceutical company specialized in ophthalmology, announces today positive results from the Phase III clinical study of Vekacia(R) in children suffering from Vernal Keratoconjunctivitis (VKC). In this orphan disease, it was shown that both symptoms and signs of disease improved in patients receiving Vekacia(R). Furthermore, the tolerability to Vekacia(R) was excellent.

VKC is a severe form of chronic allergic conjunctivitis characterized by ocular discomfort, pain, itching and intense photophobia, which severely debilitates the patients. This rare disease affects mostly children and young adults living in warm climates worldwide. In March 2006, Novagali received European Medicines Agency (EMEA) orphan drug designation for Vekacia(R) in the treatment of VKC.

The study was conducted by key experts and opinion leaders in the field of ocular allergy throughout Europe and Mediterranean area and lead by Pr David Ben Ezra, Hadassah Hebrew University Hospital, Jerusalem, who first reported on the use and potential efficacy of Cyclosporine A for the treatment of VKC.

Vekacia(R) is a topical Cyclosporine A cationic emulsion enabling an efficient and unmatched-level drug absorption in tissues of the eye leading to optimal therapeutic efficacy. This proprietary ophthalmic emulsion of Cyclosporine A will be the first therapeutic product dedicated to treatment of such a severe ocular condition.

"We achieved a major corporate milestone completing our first phase III clinical trial" declares Jerome Martinez, President & CEO of Novagali, "I am very enthusiastic about the confirmation of the high potential of Novasorb(R) cationic emulsion technology through the development of Vekacia(R) and its successful use in VKC. It is very encouraging for the other ongoing projects".

"It is a great satisfaction to b
'"/>




Page: 1 2

Related medicine technology :

1. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis

Post Your Comments:
(Date:12/3/2009)...wire-FirstCall/ -- Allen Medical Systems, a subsid...day announced the launch of its new Allen Amatech(... website www.AllenAmatech.com . ,, The webs...y and includes an online version of the new produc...pecifications for the products. "We hope to make t...
(Date:12/3/2009)...wire-FirstCall/ -- A genetic variation that may in...y life-threatening blood disorder if exposed to ce... of several medical discoveries scientists at canc...GX ) will present during the 51st American Society..., December 5-8, 2009, in New Orleans, LA. ,, I...
(Date:12/3/2009)... Ted Karkus, Chairman and... www.quigleyco.com announced today that the Compa...es to develop prescription pharmaceutical and OTC ...interests to focus primarily on the OTC/Personal C...ited to its Cold-EEZE® and Kids-EEZE® br...
Breaking Medicine Technology:Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Depression Anxiety Bad for the Heart 50336 1Depression Anxiety Bad for the Heart 50336 2Depression Anxiety Bad for the Heart 50336 3Cinergy Health Commentary on Americas Prescription Addiction 50331 1Cinergy Health Commentary on Americas Prescription Addiction 50331 2Orthopedic Surgeon Dr Marc W Hungerford a Leading Expert in Field of Avascular Necrosis Now at Baltimore 26apos 3Bs Mercy Medical Center 50326 1Orthopedic Surgeon Dr Marc W Hungerford a Leading Expert in Field of Avascular Necrosis Now at Baltimore 26apos 3Bs Mercy Medical Center 50326 2Orthopedic Surgeon Dr Marc W Hungerford a Leading Expert in Field of Avascular Necrosis Now at Baltimore 26apos 3Bs Mercy Medical Center 50326 3
...Pharmaceuticals, a division of Wyeth (NYSE: WYE )...INvestigation of TORISEL and Avastin,Combination T... phase 3b,study comparing TORISEL(R) (temsirolimus...s interferon-alfa for first-line treatment of pati...th Research is conducting the,INTORACT study with ...
... Important Factor When Selecting Treatment ... - ABSTRACT No: 5110 (Poster 6H), BASEL, S...oncology meeting in the world, the American Societ...s of managing side effects in patients,with metast...ib (Sutent(R)),are two to three times greater than...
Other Medicine Technology:Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 2Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 3Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 4Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 5Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 6Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 2Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 3
(Date:12/4/2009)...e, scientists at Johns Hopkins publishing in the D...tein made by a gene called "Twist" may be the prov...em cells that drive aggressive, metastatic breast ...g on recent work suggesting that it is a relativel...t drives breast cancer, scientists have surmised t...
(Date:12/4/2009)...r procedure done immediately or 3 weeks later, stu...ews) -- Timing of surgical repair or reconstructio...t patient outcome, a new study has found. , Mul... knee dislocations that can occur in high-impact c...to perform surgery to repair these injuries hasn,t...
(Date:12/4/2009)...lance urged for at-risk patient groups , ...od cancers, particularly Ewing sarcomas and centra...currence, U.S. researchers have found. , The st...rvivors of the most common pediatric cancers who w...y. , The researchers found that the overall can...
(Date:12/4/2009)...ey spurred blood vessel growth after heart attack ...dult stem cells appear to help repair heart attack... of 53 patients found that stem cells from donor b...s in heart tissue damaged by heart attack. , Th...n 10 days of having a heart attack. During follow-...
(Date:12/4/2009)...TON, Dec. 4 As Congress...Family Research Council (FRC) today announced an e... Louisiana to survey each household on provisions ...rtion funding, rationing, higher taxes, and govern...y participants who express opposition to the so-ca...
Breaking Medicine News(10 mins):Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover 2
...heir amorous intentions by exchanging bursts of el... Scientists describe this behavior as being somew... According to the study, which has been repo...lectric fish was largely a private matter, claims ...
...at global warming can be prevented if people acros...'Beatle' feels that the suggestion that livestock ...h. "Livestock farming is one of the bigg...s saying. "And it's all done in the name ...
...red meat, starches and sweets is linked to a rise ...an , according to a study by US and Chinese resear... interviewing subjects from the 1990s Shanghai Bre... move from a diet heavy on vegetables, soy-based p...
...uent Singapore have surged to their highest level ...figures showed Tuesday . Health ministry f...the second week in a row that the number of cases ...tional Environment Agency said in a joint statemen...
... arthritis drug Actemra has proved successful in a...ymptoms of rheumatoid arthritis in difficult-to-t... closer to regulatory approval. The Radiate st...rexate in patients who had an inadequate response ...
...stioning the benefits of taking an ice bath after ...nce runner, says that this is the secret of her su... bath to Sportsmen and women to prevent muscle sor...od vessels to tighten, and drains the blood along ...
Other Medicine News:Health News:Amorous African Fish Exchange Electric Pulses While Mating 2Health News:Ice Bath by Sports Star Questioned 2
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: